German measles, also known as rubella, is a viral infection caused by the rubella virus. It is characterized by a distinctive red rash that typically starts on the face and spreads to the rest of the body. Rubella is generally a mild illness, but it poses significant risks to pregnant women, as infection during early pregnancy can lead to congenital rubella syndrome (CRS) in the developing fetus. CRS can result in severe birth defects, including hearing impairment, heart abnormalities, and developmental delays. The symptoms of rubella include a low-grade fever, swollen lymph nodes, and a rash that lasts for a few days. The virus is highly contagious and primarily spreads through respiratory droplets from an infected person. Vaccination, usually administered as part of the MMR (measles, mumps, and rubella) vaccine, has been instrumental in reducing the incidence of rubella and preventing its associated complications. Public health efforts, including widespread vaccination campaigns, have made significant strides in controlling rubella globally. The goal is to achieve high vaccination coverage to establish herd immunity and protect vulnerable populations, particularly pregnant women and their unborn children.
Title : Extensively drug-resistant bacterial infections: Confronting a global crisis with urgent solutions in prevention, surveillance, and treatment
Yazdan Mirzanejad, University of British Columbia, Canada
Title : Pathogen-derived noncanonical epitopes: Are they valuable targets for novel vaccinations and shall we be concerned about autoimmune responses?
Michele Mishto, Francis Crick Institute, United Kingdom
Title : Bioterrorism through the ages: Historical perspective, emerging threats, and medical countermeasures
Claudia Ferreira, Sorbonne University, France
Title : When acute EBV mimics HIV: A case of false positive p24 antigen and low-level HIV antibody reactivity
Smriti Chaudhary, Imperial College Healthcare NHS Trust, United Kingdom
Title : OnePeru: Peruvian bioinformatics platform to contribute to the fight against antimicrobial resistance
Pool Marcos Carbajal, University of San Martin de Porres, Peru
Title : Measles vaccination coverage indicators in 2023 and advance towards measles elimination and eradication by 2030
Pedro Plans Rubio, College of Physicians of Barcelona, Spain